Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 7,8,13,13a-tetradehydro-2,3-9,10-bis(methylenedioxy)berbinium
2. Coptisine
1. 6020-18-4
2. Coptisine, Chloride
3. Coptisine (chloride)
4. Coptisine Hydrochloride
5. Coptisin Chloride
6. Bis[1,3]benzodioxolo[5,6-a:4',5'-g]quinolizinium, 6,7-dihydro-, Chloride
7. 6020-18-4 (chloride)
8. Nsc-119754
9. Q-100696
10. 6,7-dihydro-[1,3]dioxolo[4',5':7,8]isoquinolino[3,2-a][1,3]dioxolo[4,5-g]isoquinolin-5-ium Chloride
11. Coptisine-chloride
12. Bis(1,3)benzodioxolo(5,6-a:4',5'-g)quinolizinium, 6,7-dihydro-, Chloride
13. Nsc 119754
14. Unii-4rsb8uy88e
15. 4rsb8uy88e
16. Schembl154528
17. Chembl498722
18. Coptisine Chloride, Hplc Grade
19. Dtxsid00975628
20. Bcp25760
21. Ex-a4900
22. Hy-n0736
23. Mfcd00016676
24. Nsc119754
25. Akos015903376
26. Berbinium, 7,8,13,13a-tetradehydro-2,3:9,10-bis(methylenedioxy)-, Chloride
27. Coptisine Chloride, >=98% (hplc)
28. Ccg-268102
29. Coptisine Chloride, Analytical Standard
30. Cs-4825
31. Ac-34919
32. Bis(methylenedioxy)protoberberine Chloride
33. Bs-17288
34. Ft-0665166
35. N1701
36. A14541
37. Bis[1,6-a:4',5'-g]quinolizinium, 6,7-dihydro-, Chloride
38. 6,7-dihydro-bis[1,3]benzodioxolo[5,6-a:4',5'-g]quinolizinium Chloride
39. Berbinium,8,13,13a-tetradehydro-2,3:9,10-bis(methylenedioxy)-, Chloride
40. Q-100696; Q100696; Q 100696; Nsc-119754; Nsc119754; Nsc 119754
41. 5,7,17,19-tetraoxa-13-azoniahexacyclo[11.11.0.02,10.04,8.015,23.016,20]tetracosa-1(13),2,4(8),9,14,16(20),21,23-octaene;chloride
42. 6,7-dihydro-2h,10h-[1,3]dioxolo[4,5-g][1,3]dioxolo[7,8]isoquinolino[3,2-a]isoquinolin-5-ium Chloride
Molecular Weight | 355.8 g/mol |
---|---|
Molecular Formula | C19H14ClNO4 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 0 |
Exact Mass | 355.0611356 g/mol |
Monoisotopic Mass | 355.0611356 g/mol |
Topological Polar Surface Area | 40.8 Ų |
Heavy Atom Count | 25 |
Formal Charge | 0 |
Complexity | 502 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
78
PharmaCompass offers a list of Coptisine Chloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Coptisine Chloride manufacturer or Coptisine Chloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Coptisine Chloride manufacturer or Coptisine Chloride supplier.
PharmaCompass also assists you with knowing the Coptisine Chloride API Price utilized in the formulation of products. Coptisine Chloride API Price is not always fixed or binding as the Coptisine Chloride Price is obtained through a variety of data sources. The Coptisine Chloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Coptisine Chloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Coptisine Chloride, including repackagers and relabelers. The FDA regulates Coptisine Chloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Coptisine Chloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Coptisine Chloride supplier is an individual or a company that provides Coptisine Chloride active pharmaceutical ingredient (API) or Coptisine Chloride finished formulations upon request. The Coptisine Chloride suppliers may include Coptisine Chloride API manufacturers, exporters, distributors and traders.
Coptisine Chloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Coptisine Chloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Coptisine Chloride GMP manufacturer or Coptisine Chloride GMP API supplier for your needs.
A Coptisine Chloride CoA (Certificate of Analysis) is a formal document that attests to Coptisine Chloride's compliance with Coptisine Chloride specifications and serves as a tool for batch-level quality control.
Coptisine Chloride CoA mostly includes findings from lab analyses of a specific batch. For each Coptisine Chloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Coptisine Chloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Coptisine Chloride EP), Coptisine Chloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Coptisine Chloride USP).